Study on Treating Basal and Squamous Cell Skin Cancers with Laser Therapy and Tirbanibulin Ointment
Sponsor: Bruce Robinson, MD
ClinicalTrials ID:NCT07010692
This clinical trial is testing a new approach to treat basal and squamous cell skin cancers using a combination of laser therapy and a special ointment. The goal is to reduce the need for surgery and improve cosmetic results.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
The study aims to find out if using fractional laser therapy along with tirbanibulin ointment can effectively treat basal and squamous cell skin cancers. The treatment involves using two types of lasers, thulium and erbium, on skin cancers that have been confirmed by a biopsy. After the laser treatment, patients may need to apply the ointment for five nights, depending on how deep the cancer is. This approach hopes to offer a less invasive option that maintains the skin's appearance and is suitable for many people.
Eligibility Criteria
Inclusion Criteria
- Have a confirmed diagnosis of squamous or basal cell skin cancer that has not been treated by other methods.
Exclusion Criteria
- Cannot be pregnant at the time of treatment.
Locations
| FACILITY | ZIP | CITY | STATE |
|---|---|---|---|
| Bruce Robinson, MD | 10022 | New York | New York |
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.